Ashwagandha (Withania somnifera [L.] Dunal)	Placebo	Quality of Life scores at 12 weeks	1505	1650	The QOL scores for all subdomains significantly improved to a greater extent in the Ashwagandha group at 12 weeks compared to placebo (P < 0.05).
Ashwagandha (Withania somnifera [L.] Dunal)	Placebo	Increase from baseline in the mean VO2 max after 8 weeks	1280	1458	There was a greater increase from baseline (P < 0.0001) in the mean VO2 max with KSM-66 Ashwagandha (n = 24) compared to placebo (n = 25) at 8 weeks (4.91 and 1.42, respectively)
Ashwagandha (Withania somnifera [L.] Dunal)	Placebo	Quality of Life scores at 8 weeks	11213	11362	the status of the environmental impact on the QOL of the study subjects was found to have increased substantially; albeit, not significant at 8 weeks
Ashwagandha (Withania somnifera [L.] Dunal)	Placebo	Quality of Life scores at 8 weeks	11204	11362	However, the status of the environmental impact on the QOL of the study subjects was found to have increased substantially; albeit, not significant at 8 weeks
Ashwagandha (Withania somnifera [L.] Dunal)	Placebo	Vital parameters	11423	11594	There were no changes in the vital parameters such as pulse rate, blood pressure (systolic and diastolic), and respiratory at resting state in the subjects of both groups.
